Zobrazeno 1 - 10
of 87
pro vyhledávání: '"Emelia J. Benjamin"'
Autor:
Christopher D. Anderson, Ludovic Trinquart, Jeffrey M. Ashburner, Shaan Khurshid, Darae Ko, Lee H. Schwamm, Daniel E. Singer, Xinye Li, Steven J. Atlas, Priscilla R Lee, Patrick T. Ellinor, Emelia J. Benjamin, Ana T. Trisini Lipsanopoulos, Steven A. Lubitz, Aimee K. Lin
Publikováno v:
The American Journal of Cardiology. 147:44-51
We characterized monitor utilization in stroke survivors and assessed associations with underlying clinical atrial fibrillation (AF) risk. We retrospectively analyzed consecutive patients with acute ischemic stroke 10/2018-6/2019 without prevalent AF
Autor:
Andrea M. Russo, Marmar Vaseghi, Albert L. Waldo, Odayme Quesada, Carl J. Pepine, Emelia J. Benjamin, Kathryn J. Lindley, Nanette K. Wenger, Annabelle Santos Volgman, Anne B. Curtis, Gerald V. Naccarelli, Margaret C. Fang
Publikováno v:
J Cardiovasc Electrophysiol
Atrial fibrillation (AF) remains a growing problem in the United States and worldwide, imposing a high individual and health system burden, including increased resource consumption due to repeated hospitalizations, stroke, dementia, heart failure, an
Autor:
Margaret C. Fang, Andrea M. Russo, C. Noel Bairey Merz, Annabelle Santos Volgman, Marmar Vaseghi, Anne B. Curtis, Nanette K. Wenger, Emelia J. Benjamin, Carl J. Pepine, Kathryn J. Lindley, Albert L. Waldo
Publikováno v:
J Am Coll Cardiol
Atrial fibrillation (AF), a worldwide epidemic, contributes to frequent hospitalizations, stroke, heart failure, disability, mortality, and health-resource consumption ([1][1]). AF affects people differently with regard to sex, race, ethnicity, and s
Autor:
Emelia J. Benjamin, Darae Ko, Tenes Paul, Allan J. Walkey, David D. McManus, Hammad Sadiq, Ziyue Wang, Connor Saleeba, Qiming Shi, Steven A. Lubitz, Alok Kapoor, Sybil L. Crawford
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 10, Iss 21 (2021)
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Background Atrial fibrillation (AF) commonly occurs in the setting of acute conditions. We aimed to identify the acute conditions associated with secondary AF (AF precipitants) including pneumonia/sepsis, pneumothorax, respiratory failure, myocarditi
Autor:
Jingchuan Guo, Nico Gabriel, Jared W. Magnani, Utibe R. Essien, Walid F. Gellad, Maria M. Brooks, Ludovic Trinquart, Emelia J. Benjamin, Inmaculada Hernandez
Publikováno v:
Frontiers in Public Health, Vol 9 (2021)
Frontiers in Public Health
Frontiers in Public Health
Objective: Atrial fibrillation (AF) may remain undiagnosed until the development of complications. We aimed to examine the epidemiology and racial/ethnic and rural/urban differences in the frequency of newly diagnosed AF manifesting as ischemic strok
Autor:
Xinye Li, Patrick T. Ellinor, Ana T. Trisini Lipsanopoulos, Corban Jackson, Priscilla R Lee, Steven J. Atlas, Taylor Carmichael, Shaan Khurshid, Darae Ko, Daniel E. Singer, Xin Wang, Steven A. Lubitz, Ludovic Trinquart, Jeffrey M. Ashburner, Christopher D. Anderson, Emelia J. Benjamin, Ashby C Turner
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 10, Iss 21 (2021)
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 10, Iss 21 (2021)
Background Performance of existing atrial fibrillation (AF) risk prediction models in poststroke populations is unclear. We evaluated predictive utility of an AF risk model in patients with acute stroke and assessed performance of a fully refitted mo
Autor:
Annabelle Santos, Volgman, Gatha, Nair, Radmila, Lyubarova, Faisal M, Merchant, Pamela, Mason, Anne B, Curtis, Nanette K, Wenger, Neelum T, Aggarwal, James N, Kirkpatrick, Emelia J, Benjamin
Publikováno v:
Journal of the American College of Cardiology. 79(2)
The prevalence of atrial fibrillation (AF) is increasing as the population ages. AF treatment-related complications also increase markedly in older adults (defined as ≥75 years of age for this review). The older AF population has a high risk of str
Autor:
Emelia J. Benjamin, Veikko Salomaa, Lu-Chen Weng, Kathryn L. Lunetta, Christopher D. Anderson, Brandon K. Fornwalt, Samuli Ripatti, Christopher M. Haggerty, Qiuxi Huang, Steven A. Lubitz, Shaan Khurshid, Dustin N. Hartzel, Ludovic Trinquart, Jeffrey M. Ashburner, Patrick T. Ellinor, Nina Mars
Publikováno v:
Circ Genom Precis Med
Background: Atrial fibrillation (AF) risk estimation using clinical factors with or without genetic information may identify AF screening candidates more accurately than the guideline-based age threshold of ≥65 years. Methods: We analyzed 4 samples
Autor:
Patrice Desvigne-Nickens, Ileana L. Piña, Ratika Parkash, Mark S. Link, Paul J. Wang, Sana M. Al-Khatib, Mellanie True Hills, Anne M. Gillis, Daniel E. Forman, Paulus Kirchhof, David R. Van Wagoner, Emelia J. Benjamin, Jeroen M.L. Hendriks, Katherine T. Murray, Michiel Rienstra, Gregory M. Marcus, Luc Djoussé, Alan S. Go, Reena Mehra, Prashanthan Sanders, Alvaro Alonso, Susan Redline, Lawton S. Cooper, Virend K. Somers
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Journal of the American Heart Association, vol 10, iss 16
Journal of the American Heart Association, 10(16):e021566. Wiley
Journal of the American Heart Association, vol 10, iss 16
Journal of the American Heart Association, 10(16):e021566. Wiley
There has been sustained focus on the secondary prevention of coronary heart disease and heart failure; yet, apart from stroke prevention, the evidence base for the secondary prevention of atrial fibrillation (AF) recurrence, AF progression, and AF
Autor:
Christian Herder, Marju Orho-Melander, Ron C. Hoogeveen, Sudha Seshadri, Marios K. Georgakis, Tiberiu A Pana, Mohamed A. Elhadad, S. Matthijs Boekholdt, Colby Ayers, Christie M. Ballantyne, Wolfgang Koenig, Myriam Fornage, Olle Melander, James A. de Lemos, Serkalem Demissie, Rainer Malik, Alexa S. Beiser, Alexandru Schiopu, Martin Söderholm, Annette Peters, Nicholas J. Wareham, Phyo K. Myint, Martin Dichgans, Harry Björkbacka, Jan Nilsson, Gunnar Engström, Emelia J. Benjamin
Publikováno v:
Circ. Res. 125, 773-782 (2019)
Circulation research, 125(8), 773-782. Lippincott Williams and Wilkins
Circulation research 125(8), 773-782 (2019). doi:10.1161/CIRCRESAHA.119.315380
Circulation research, 125(8), 773-782. Lippincott Williams and Wilkins
Circulation research 125(8), 773-782 (2019). doi:10.1161/CIRCRESAHA.119.315380
Rationale: Proinflammatory cytokines have been identified as potential targets for lowering vascular risk. Experimental evidence and Mendelian randomization suggest a role of MCP-1 (monocyte chemoattractant protein-1) in atherosclerosis and stroke. H